The ability of purified TRPM7 kinase domain to phosphorylate the CREB peptide led to the identification of TG100–115 as a new inhibitor of TRPM7 kinase activity and breast cancer cell migration [44]. The gene discussed is TRPM7; the disease is breast carcinoma.